UChicago Annual Updates from ASH 2019

 

UChicago Annual Updates from ASH 2019
S

Inherited Predisposition to Myeloid Hematologic Malignancies: Why Does Identification of Germline Predisposition Syndromes Matter?

By UChicago Annual Updates from ASH 2019 FEATURING Simone Feurstein
By UChicago Annual Updates from ASH 2019 FEATURING Simone Feurstein
53 views
March 20, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

11:12
Stemline

A proven CD123 targeted therapy for BPDCN

Feat. H. Erba

Featured Video

15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
Videos
16:52

Hereditary Hematopoietic Malignancies: What to Look For, and What to…

UChicago Annual Updates from ASH 2019

M. Drazer

234 views
25:56

Inherited Predisposition to Myeloid Hematologic Malignancies: Why Do…

UChicago Annual Updates from ASH 2019

S. Feurstein

53 views
17:22

BCL2 Inhibition in Myeloid Malignancies: Venetoclax + Azacitidine in…

UChicago Annual Updates from ASH 2019

O. Odenike

295 views
12:07

Updates on Myeloid Malignancies: JAK in MF, TGFb Inhibition in MF an…

UChicago Annual Updates from ASH 2019

O. Odenike

44 views
12:13

Highlights from ASH on ALL: Role of AlloSCT in CR1 for Young Adults …

UChicago Annual Updates from ASH 2019

W. Stock

41 views
07:26

Highlight from ASH on ALL: Frontline Therapy in Older Adults & Dual …

UChicago Annual Updates from ASH 2019

W. Stock

33 views
10:45

Updates on CAR-T Treatment of ALL: Prognosticators of Response, Dual…

UChicago Annual Updates from ASH 2019

W. Stock

30 views
13:28

ASH 2019 Updates in Multiple Myeloma: Early Intervention in High Ris…

UChicago Annual Updates from ASH 2019

J. Jasielec

108 views
16:33

ASH 2019 Updates in R/R Multiple Myeloma: Prolonged PFS with KdD, Ve…

UChicago Annual Updates from ASH 2019

J. Jasielec

30 views
09:30

ASH 2019 Updates on CAR T Cell Therapy in DLBCL: Liso-cel has Favora…

UChicago Annual Updates from ASH 2019

P. Riedell

59 views
05:40

ASH 2019 Updates on CAR T Cell Therapy in Mantle Cell Lymphoma: KTE-…

UChicago Annual Updates from ASH 2019

P. Riedell

61 views
13:18

ASH 2019 Updates on CAR T Cell Therapy in CLL/SLL: Liso-cel Active i…

UChicago Annual Updates from ASH 2019

P. Riedell

17 views
08:12

ASH 2019 Updates on PET Directed Therapy for Early Stage DLBCL

UChicago Annual Updates from ASH 2019

J. Kline

35 views
12:46

ASH 2019 Updates on FL: Obinutuzimab + Lenalidomide in Frontline Set…

UChicago Annual Updates from ASH 2019

J. Kline

127 views
10:07

ASH 2019 Updates on Hodgkin Lymphoma: Frontline Brentuximab + Nivo i…

UChicago Annual Updates from ASH 2019

J. Kline

313 views
15:37

ASH 2019 Updates on Treatment of Young 'Fit' CLL Pts: Improved PFS a…

UChicago Annual Updates from ASH 2019

N. Jain

727 views
14:45

ASH 2019 Treatment of Older FCR Ineligible CLL Pts: 5 Years Follow‐u…

UChicago Annual Updates from ASH 2019

N. Jain

19 views
09:43

ASH 2019 Updates in R/R CLL: PFS and OS Benefit with VenR, Associati…

UChicago Annual Updates from ASH 2019

N. Jain

28 views